12:00 AM
 | 
Feb 21, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

VRS-317: Phase I start

This quarter, Versartis will begin an international Phase I trial to evaluate VRS-317 in adult patients. Versartis has rights...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >